Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 2,596 shares and sold $29,024 worth of shares (1,332 units at $21.79) as part of a pre-agreed trading plan, increasing direct ownership by 5% to 29,129 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
ACAD· ACADIA Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.